These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33152919)

  • 1. Advances in non and minimal-invasive transcutaneous delivery of immunotherapy for cancer treatment.
    Nguyen TT; Nguyen TTD; Ta QTH; Vo VG
    Biomed Pharmacother; 2020 Nov; 131():110753. PubMed ID: 33152919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination.
    Sun X; Zeng L; Huang Y
    J Gene Med; 2019 Jul; 21(7):e3089. PubMed ID: 30958606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
    Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
    Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
    Han S; Huang K; Gu Z; Wu J
    Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery technologies for cancer immunotherapy.
    Riley RS; June CH; Langer R; Mitchell MJ
    Nat Rev Drug Discov; 2019 Mar; 18(3):175-196. PubMed ID: 30622344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial drug delivery approaches for immunomodulation.
    Stewart JM; Keselowsky BG
    Adv Drug Deliv Rev; 2017 May; 114():161-174. PubMed ID: 28532690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal immunomodulation: Principles, advances and perspectives.
    Zhao Z; Ukidve A; Dasgupta A; Mitragotri S
    Adv Drug Deliv Rev; 2018 Mar; 127():3-19. PubMed ID: 29604373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering safer immunotherapies for cancer.
    Milling L; Zhang Y; Irvine DJ
    Adv Drug Deliv Rev; 2017 May; 114():79-101. PubMed ID: 28545888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
    Inthagard J; Edwards J; Roseweir AK
    Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations.
    Xu W; Zhang X; Hu X; Zhiyi C; Huang P
    Cancer Lett; 2019 Sep; 460():86-95. PubMed ID: 31254552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous drug delivery: a practical review.
    Berti JJ; Lipsky JJ
    Mayo Clin Proc; 1995 Jun; 70(6):581-6. PubMed ID: 7776720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.
    Asadi N; Davaran S; Panahi Y; Hasanzadeh A; Malakootikhah J; Fallah Moafi H; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):18-23. PubMed ID: 27196810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
    Cheng CT; Castro G; Liu CH; Lau P
    Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.
    Mikelez-Alonso I; Aires A; Cortajarena AL
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System.
    Muluh TA; Chen Z; Li Y; Xiong K; Jin J; Fu S; Wu J
    Int J Nanomedicine; 2021; 16():2389-2404. PubMed ID: 33790556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microneedles for drug and vaccine delivery.
    Quinn HL; Kearney MC; Courtenay AJ; McCrudden MT; Donnelly RF
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1769-80. PubMed ID: 25020088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy.
    Francis DM; Thomas SN
    Adv Drug Deliv Rev; 2017 May; 114():33-42. PubMed ID: 28455187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.